Aus CVD risk: the Australian cardiovascular disease risk calculator

The 2023 Aus CVD Risk calculator and guideline provide updated evidence-based recommendations for identifying, assessing, communicating and managing CVD risk in a primary prevention setting.

Fluoxetine: can it decrease weight in obese and overweight patients?

This evidence summary presents the best available evidence on the effectiveness of fluoxetine in decreasing weight.

Giving a voice back to elderly patients

Yesterday’s National Medicine Symposium delivered a stark critique of how our health system is failing older patients – and how to fix it.

Understanding the barriers to RMMRs

Residential medication management reviews have proven to be beneficial in identifying medicine-related problems, so why are they so under-utilised?

Top tips for a difficult hay fever season

Changing weather patterns could spell trouble ahead for hay fever sufferers. Now is the time to ensure patients have optimum relief.

ATAGI highlights progress amid resurgent diseases

ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.